Table 1.
General characteristics of the ADC patients
Factors | Patient Number (%) | |
---|---|---|
Age (year) | Median (Range) | 58 (52.9, 47.1) |
< 50 | 23 (15) | |
≥ 50 | 130 (85) | |
Gender | Male | 77 (50.3) |
Female | 76 (49.7) | |
Smoking | Never | 90 (58.8) |
Former or current | 63 (41.2) | |
Tumor Size (cm) | Median (Range) | 3 (49,51) |
≤ 3 | 75 (49) | |
> 3 | 78 (51) | |
Histological type | Acinar predominant | 56 (36.6) |
Lepidic predominant | 51 (33.3) | |
Papilary predominant | 17 (11.1) | |
Solid predominant | 17 (11.1) | |
Micropapilary predominant | 12 (7.8) | |
TNM | TNMI | 55 (35.9) |
TNMII | 40 (26.2) | |
TNMIII | 39 (25.5) | |
TNMIV | 19 (12.4) | |
NSE | Median (Range) | 11.85 (50.3, 49.7) |
≤ 15.2 ug/ml | 129 (84.3) | |
> 15.2 ug/ml | 24 (15.7) | |
TPSA | Median (Range) | 45.41 (50.3, 49.7) |
≤ 80 ug/ml | 124 (81) | |
> 80 ug/ml | 29 (19) | |
SCC | Median (Range) | 0.7 (56.9, 43.1) |
≤ 1.5 ug/ml | 144 (94.1) | |
> 1.5 ug/ml | 9 (5.9) | |
CEA | Median (Range) | 3.87 (50.65, 49.35) |
≤ 5 ug/ml | 90 (58.8) | |
> 5 ug/ml | 63 (41.2) | |
Cyfra 21-1 | Median (Range) | 2.53 (50.3, 49.7) |
≤ 3.3 ug/ml | 106 (69.3) | |
> 3.3 ug/ml | 47 (30.7) | |
CAMKII | Low | 63 (41.2) |
High | 90 (58.8) | |
EGFR | Mutation | 56 (36.6) |
Wild | 97 (63.4) |